VBI Vaccines
VBIV
$0.58
Share price
2.30%
Change (1 day)
-79.84%
Change (1 year)
Categories
VBI Vaccines (VBIV) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $79.42 M
According to VBI Vaccines 's latest financial reports the company's total liabilities are $79.42 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
VBI Vaccines - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $90.92 M | 36.94% |
| 2021-12-31 | $66.39 M | 76.27% |
| 2020-12-31 | $37.66 M | 10.96% |
| 2019-12-31 | $33.94 M | -14% |
| 2018-12-31 | $39.47 M | 52.58% |
| 2017-12-31 | $25.86 M | 23.05% |
| 2016-12-31 | $21.02 M | 333.37% |
| 2015-12-31 | $4.85 M | |
| 2015-03-31 | $0.27 M | 11.14% |
| 2014-03-31 | $0.24 M | 3.66% |
| 2013-03-31 | $0.24 M | -66.19% |
| 2012-03-31 | $0.7 M | -98.57% |
| 2011-03-31 | $49.52 M | 24089.48% |
| 2010-03-31 | $0.2 M | 27.31% |
| 2009-03-31 | $0.16 M | -17% |
| 2008-03-31 | $0.19 M | 36.76% |
| 2007-03-31 | $0.14 M | -42.24% |
| 2006-03-31 | $0.24 M | -0.27% |
| 2005-03-31 | $0.24 M | 38.42% |
| 2004-03-31 | $0.17 M | -8.76% |
| 2003-03-31 | $0.19 M | 46.22% |
| 2002-03-31 | $0.13 M | 189.03% |
| 2001-03-31 | $0.04 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Onconova Therapeutics ONTX | $12.01 M | -84.88% | 🇺🇸 USA |
 Curis CRIS | $57.61 M | -27.46% | 🇺🇸 USA |
 Myriad Genetics MYGN | $0.36 B | 357.42% | 🇺🇸 USA |